ADX-038, Sodio cloruro Galenica Senese 0,9% solvente per uso parenterale
ADX-038-202
Phase 2 small_molecule active
Quick answer
ADX-038, Sodio cloruro Galenica Senese 0,9% solvente per uso parenterale for Geographic atrophy secondary to age-related macular degeneration is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Geographic atrophy secondary to age-related macular degeneration
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active